N-(5-{[(3Z)-3-Amino-3-Iminopropyl]Carbamoyl}-1-Methyl-1H-Pyrrol-3-Yl)-4-{[N-(Diaminomethylidene)Glycyl]Amino}-1-Methyl-1H-Pyrrole-2-Carboxamide

N-(5-{[(3Z)-3-Amino-3-Iminopropyl]Carbamoyl}-1-Methyl-1H-Pyrrol-3-Yl)-4-{[N-(Diaminomethylidene)Glycyl]Amino}-1-Methyl-1H-Pyrrole-2-Carboxamide


    • Product Name N-(5-{[(3Z)-3-Amino-3-Iminopropyl]Carbamoyl}-1-Methyl-1H-Pyrrol-3-Yl)-4-{[N-(Diaminomethylidene)Glycyl]Amino}-1-Methyl-1H-Pyrrole-2-Carboxamide
    • Mininmum Order 1mg
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    727157

    As an accredited N-(5-{[(3Z)-3-Amino-3-Iminopropyl]Carbamoyl}-1-Methyl-1H-Pyrrol-3-Yl)-4-{[N-(Diaminomethylidene)Glycyl]Amino}-1-Methyl-1H-Pyrrole-2-Carboxamide factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 100g of N-(5-{[(3Z)-3 - amino - 3 - iminopropyl]carbamoyl}-1 - methyl - 1H - pyrrol - 3 - yl)-4-{[N-(diaminomethylidene)glycyl]amino}-1 - methyl - 1H - pyrrole - 2 - carboxamide in sealed chemical - grade package.
    Shipping The chemical "N-(5-{[(3Z)-3 -Amino-3 -Iminopropyl]Carbamoyl}-1 -Methyl-1H -Pyrrol-3 -Yl)-4-{[N-(Diaminomethylidene)Glycyl]Amino}-1 -Methyl-1H -Pyrrole-2 -Carboxamide" will be shipped in proper, sealed containers, following all hazardous chemical shipping regulations to ensure safe transit.
    Storage Store the chemical N-(5-{[(3Z)-3 - Amino - 3 - Iminopropyl]Carbamoyl}-1 - Methyl - 1H - Pyrrol - 3 - Yl)-4-{[N-(Diaminomethylidene)Glycyl]Amino}-1 - Methyl - 1H - Pyrrole - 2 - Carboxamide in a cool, dry place away from direct sunlight. Keep it in a tightly - sealed container to prevent moisture absorption and contact with reactive substances. Ensure proper labeling for easy identification and safety.
    Application of N-(5-{[(3Z)-3-Amino-3-Iminopropyl]Carbamoyl}-1-Methyl-1H-Pyrrol-3-Yl)-4-{[N-(Diaminomethylidene)Glycyl]Amino}-1-Methyl-1H-Pyrrole-2-Carboxamide

    Synthesis of the aromatic diamidine antiprotozoal candidate that targets the kinetoplast DNA network in Trypanosoma brucei relies on late-stage elaboration of this N-methylpyrrole carboxamide precursor. The bis-pyrrole scaffold, bearing a (3Z)-3-amino-3-iminopropyl amide terminus, is activated as a mixed anhydride at -15 ± 2 °C using isobutyl chloroformate (1.05 eq) and N-methylmorpholine (1.2 eq) in anhydrous tetrahydrofuran (THF, water content ≤50 ppm by Karl Fischer titration). A countercurrent extractive workup with chilled 0.5 M phosphate buffer (pH 6.8) removes N-methylmorpholine hydrochloride and excess chloroformate prior to coupling with a substituted phenylamidine amine nucleophile. The heterogeneous coupling cascade, monitored by in-line ReactIR for the disappearance of the anhydride carbonyl stretch at 1825 cm⁻¹, achieves conversion of ≥95% within 45 minutes when the jacket temperature is ramped to 0 °C post-addition. Crude product is isolated by drowning into ice-water (10 volumes) and the filter cake is triturated with methyl tert-butyl ether to remove non-polar byproducts. Final recrystallization from ethyl acetate/n-heptane (2:1 v/v) yields a white crystalline solid with HPLC purity of 99.0% (area%, λ = 260 nm). Downstream manufacturers consolidating this intermediate for preclinical toxicology batches must document control of the (E/Z)-isomer ratio of the aminoiminopropyl sidechain; the (3Z)-configuration is essential for DNA minor-groove isohelical fit, and batch-to-batch variance exceeding 5% of the (E)-isomer has been correlated with a 0.9-log reduction in EC₅₀ against T. b. brucei bloodstream forms in vitro. Residual palladium from upstream Sonogashira or Buchwald-Hartwig routes that may have installed the pyrrole–pyrrole linkage is limited to <1 ppm per ICH Q3D Option 1 oral PDE-based control. The terminal active pharmaceutical ingredient is a lyophilized dihydrochloride salt administered via intramuscular injection, requiring the intermediate to pass bacterial endotoxin testing at <0.15 EU/mg when designated for parenteral-grade synthesis. Published data for this specific configuration is limited to internal process development reports; however, the general structural class has demonstrated photostability under ICH Q1B Option 2 conditions with a 92% mass balance at 200 Wh/m².

    What Limits the Scale-Up of Guanidine-Containing Oligopyrrole Amides Under Oxygen-Free Coupling Protocols?

    The primary bottleneck encountered during production of multi-kilogram batches of this intermediate lies in the suppression of oxidative side reactions on the electron-rich pyrrole nuclei and the unprotected guanidine glycyl pendant. In bench-scale syntheses (<500 g), the sequential amide bond formation between 4-amino-1-methylpyrrole-2-carboxylic acid derivatives and the glycyl-guanidine building block is conducted under a positive pressure of argon (99.999% purity) with three vacuum-purge cycles to maintain a headspace oxygen concentration below 200 ppm. At the 50-L HASTELLOY C-22 reactor scale, the same coupling mediated by COMU®/collidine in N,N-dimethylformamide (DMF, stored over activated 4A molecular sieves) develops a deep amber hue and a characteristic isocyanide-like odor if the agitator seal leaks ambient air. The formation of an insoluble, crosslinked oligomeric precipitate — tentatively identified as a pyrrole-pyrrole oxidative coupling product by GPC analysis — reduces the isolated yield from a laboratory-observed 78% to 31–44%. Solutions adopted in contract manufacturing organizations include switching to a N-methyl-2-pyrrolidone (NMP)/sulfolane (7:3 v/v) solvent system, which retards radical propagation due to its relatively high viscosity (10.3 cP at 25 °C) and low oxygen solubility, and the introduction of 0.1 wt% 2,6-di-tert-butyl-4-methylphenol (BHT) as a sacrificial antioxidant. The coupling temperature must be strictly maintained at -5 to 0 °C over a 12-hour holding period to avoid racemization of the guanidine glycyl moiety; a deviation to +5 °C results in a 1.2% increase in the D-enantiomeric impurity detectable by chiral SFC-MS. Every campaign must document the residual solvent profile per USP <467> and demonstrate that DMF and NMP are below their respective permitted daily exposures (880 ppm and 530 ppm for a 10 g/day intake scenario). The purified intermediate, if stored under nitrogen at -20 °C in amber borosilicate glass, retains ≤0.2% total degradants for 24 months, a stability datum critical for inclusion in a Type II drug master file.

    Terminal Aminoimino Function as a Masked Hydrazine Handle for Site-Specific Bioconjugation

    Introducing aldehyde-reactive handles into payloads for antibody–drug conjugates (ADCs) frequently exploits the reversible condensation of the (3Z)-3-amino-3-iminopropyl moiety with aromatic aldehydes under mildly acidic conditions. This compound is a heterobifunctional linker progenitor: the bis-pyrrole amide core acts as a rigid spacing element, the guanidine group confers aqueous solubility, and the terminal aminoimino group functions as a latent hydrazine equivalent. In a typical bioconjugation protocol, the intermediate is dissolved in 100 mM sodium acetate buffer (pH 4.5) containing 5% (v/v) acetonitrile as cosolvent and added at 5 molar equivalents relative to the formylglycine-engineered monoclonal antibody (FG-mAb, ~2 aldehyde sites/mAb generated by formylglycine-generating enzyme). The reaction mixture is rotated at 4 °C for 16 hours, after which the hydrazone conjugate is stabilized by reduction with sodium cyanoborohydride (10 mM final, quenched with Tris). Unconjugated small molecule is removed by tangential flow filtration using a 30 kDa PES membrane cassette, reducing the free drug-related impurity level to ≤0.1% per LC-MS analysis. The resulting drug-to-antibody ratio (DAR) of 1.8–2.0 is verified by hydrophobic interaction chromatography. A critical regulatory requirement under ICH Q6B and FDA guidance “Microbiology Data for Antibacterial Drugs” is the demonstration that the linker-payload intermediate is free of β-lactam impurities and adventitious endotoxins (<0.01 EU/mg). The conjugated ADC, targeting folate receptor α, exhibited a mean hydrodynamic diameter of 12.8 nm by dynamic light scattering, with 98% monomer purity by SEC-HPLC; these metrics are submitted in the Chemistry, Manufacturing, and Controls (CMC) section of an Investigational New Drug (IND) application. Published data for this specific configuration remain limited to conference abstracts; however, analogous netropsin-derived linkers have shown plasma stability over 7 days in mouse serum at 37 °C.

    For targeted enrichment of AT-rich repetitive elements in long-read sequencing libraries, the compound functions as a minor-groove-directed precipitation reagent that selectively binds and aggregates double-stranded DNA fragments with consecutive adenine–thymine stretches. A working solution is prepared by dissolving the dihydrochloride salt of the intermediate at 0.1% (w/v) in TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 8.0) and sterile-filtering through a 0.22 µm PVDF syringe filter. Sheared genomic DNA (~20 µg/mL) is incubated with an equal volume of the precipitant solution at 25 °C for 30 minutes, after which the fine fibrous aggregate is pelleted by centrifugation at 14,000 × g for 10 minutes. The pellet is washed twice with 70% ethanol and resuspended in nuclease-free water, yielding a 4- to 6-fold enrichment of satellite III and other α-satellite repeats as confirmed by qPCR. This precipitation phenomenon is exploited in a commercial DNA purification kit format that adheres to ISO 13485 design controls; the kit insert documents that the precipitant’s lot-to-lot consistency is monitored by CLSM imaging of DAPI-stained aggregate morphology, with a required average particle diameter of 5 ± 1.5 µm. No significant interference with downstream PacBio SMRTbell library preparation has been detected when residual compound levels remain below 0.001% (w/v).

    At Low Micromolar Concentrations the Compound Serves as a Reversible Inhibitor of Human DNA Ligase I for Synthetic Lethality Studies

    Human DNA ligase I (hLigI) recognizes the nicked DNA substrate in a processive clamp mechanism, and netropsin derivatives that displace the ligase–DNA interaction have been mapped as first-in-class modulators for BRCA1-mutant synthetic lethality screens. This intermediate, dissolved in cell-culture-grade dimethyl sulfoxide (DMSO) to a stock concentration of 10 mM, is diluted into RPMI-1640 medium (supplemented with 10% fetal bovine serum, 1% penicillin-streptomycin) to a final assay concentration of 2.5 µM, ensuring that the DMSO vehicle does not exceed 0.1% v/v. Inhibition of ligation is quantified using a fluorescence resonance energy transfer (FRET)-based nicked duplex substrate; a pre-incubation period of 60 minutes at 30 °C reduces the initial ligation velocity by ~50% relative to the DMSO control. Cell-based experiments in MDA-MB-436 (BRCA1-deficient) breast cancer lines demonstrate a shift in the γ-H2AX foci formation kinetics when the inhibitor is co-administered with a sub-cytotoxic dose of methyl methanesulfonate (0.5 µg/mL). The bench-scale synthesis for such studies requires the intermediate in ≥99.5% purity by qNMR because the 0.1% impurity of a structurally related mono-guanidine analog has been shown to act as a competing inhibitor of the ATP-binding pocket of hLigIV, confounding the interpretation of nuclear foci resolution. Storage of the stock aliquots at -80 °C in amber microcentrifuge tubes under argon is mandatory; freeze-thaw cycles exceeding 3 result in 6% decomposition to a biologically inert cyclic urea byproduct, as tracked by LC-TOF.

    Alignment of Pharmacopoeial Quality Attributes with ISO 17034 for a DNA-Binder Reference Standard

    Certified reference material (CRM) production of this bis-pyrrole carboxamide for use as a system suitability standard in high-performance liquid chromatography–tandem mass spectrometry (HPLC-MS/MS) method validation complies with ISO 17034:2016 and ISO/IEC 17025:2017. The assigned purity of 99.72% is derived from a mass balance calculation that subtracts organic impurities (HPLC-DAD-CAD, 0.12%), water (Karl Fischer coulometric titration, 0.09%), residual solvents (headspace GC-FID, 0.04%, dominated by ethyl acetate at 410 ppm against an ICH Q3C limit of 5000 ppm), and non-volatile residue (0.03%). The expanded uncertainty (k=2) is ±0.35%. Characterization relies on 1H NMR (600 MHz, DMSO-d6) to confirm the (3Z)-geometry through the diagnostic coupling constant between the imino NH and the adjacent methylene, and on high-resolution mass spectrometry (ESI-TOF) giving [M+H]+ at m/z 472.23120.8 ppm from calculated). The CRM is packaged in amber vials sealed under argon at 100 ± 2 mg fill weight. A nine-point homogeneity study (n=10 vials, 1 determination per vial) yields a between-vial standard deviation of 0.06%, well within the 0.28% critical value from the ISO Guide 35 statistical model. Short-term stability over 4 weeks at 40 °C/75% RH reveals a 0.15% decrease in purity and an increase of the (E)-isomer to 0.34%, leading to a recommended shipping condition of 2–8 °C. End-users in quality control laboratories employ the CRM to calibrate the response factor of the main peak when testing incoming lots of the intermediate against an internal specification of ≥98.0% area purity and guanidine content by ion chromatography (≥95% of theoretical).

    Free Quote

    Competitive N-(5-{[(3Z)-3-Amino-3-Iminopropyl]Carbamoyl}-1-Methyl-1H-Pyrrol-3-Yl)-4-{[N-(Diaminomethylidene)Glycyl]Amino}-1-Methyl-1H-Pyrrole-2-Carboxamide prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Introduced in high-purity lyophilized form, the synthetic polyamide N-(5-{[(3Z)-3-Amino-3-Iminopropyl]Carbamoyl}-1-Methyl-1H-Pyrrol-3-Yl)-4-{[N-(Diaminomethylidene)Glycyl]Amino}-1-Methyl-1H-Pyrrole-2-Carboxamide serves as a sequence-specific DNA minor groove ligand engineered for recognition of extended A/T-rich tracts. Batch-to-batch consistency is maintained by reverse-phase HPLC purification with UV detection at 310 nm, yielding a net peptide content ≥ 95% and a single dominant peak. The lyophilizate is vacuum-dried to residual moisture < 0.5% (Karl Fischer titration) and sealed under argon in amber glass vials to limit photolytic degradation of the pyrrole chromophores.

    The compound carries a calculated monoisotopic mass of 515.2 g mol⁻¹ (confirmed by ESI-TOF MS), and solubility in sterile-filtered 10 mM sodium cacodylate buffer (pH 7.0) exceeds 2.5 mg mL⁻¹ when sonicated at 35 °C for 90 s. Stock solutions prepared in DMSO at 10 mM can be stored at −20 °C in single-use aliquots, avoiding repeated freeze–thaw cycles that promote N-terminal amidine tautomerization and loss of binding competence.

    Structural Determinants of Minor Groove Affinity

    The antiparallel fold adopted by two N-methylpyrrole-2-carboxamide subunits enables the molecule to trace the narrow minor groove of double-stranded DNA with isohelical fidelity. Each pyrrole ring donates an amide N–H hydrogen bond to a purine N3 or pyrimidine O2 atom, while the N-methyl substituents fill the groove sterically, excluding water and increasing van der Waals contacts. The C-terminal segment bears a diaminomethylidene-glycyl extension that introduces an additional guanidino hydrogen-bond donor pair; isothermal titration calorimetry data acquired on synthetic hairpin oligomers show that this modification lowers the dissociation constant (Kd) by 0.8–1.2 kcal mol⁻¹ relative to the des-glycyl analog at 25 °C in 100 mM KCl, 10 mM Tris-HCl (pH 7.5).

    The (3Z) configuration of the amino-iminopropyl side chain stabilizes an intramolecular contact between the terminal amidine and the adjacent amide carbonyl, pre-organizing the ligand into a crescent-like conformation that matches the 4.5–5.0 Å phosphate-phosphate distance across the minor groove. Circular dichroism spectra recorded at 260 nm exhibit a positive induced Cotton effect upon binding to poly(dA)·poly(dT), consistent with a single orientation in the groove and a right-handed helical twist.

    How Does the (3Z)-Amino-Iminopropyl Moiety Influence Binding Specificity?

    Quantitative DNase I footprinting on 275 bp restriction fragments derived from the Xenopus borealis 5S RNA gene demonstrates that the ligand protects 6–7 contiguous A/T base pairs with a site-size of 0.6–0.7 turns of the DNA helix. Discrimination against single G·C substitutions within the target site is > 100-fold, as assessed by the loss of footprint at 1 μM ligand concentration. When the iminopropyl stereochemistry is inverted to the (3E) isomer, the footprint boundary shifts by ±1 bp and partial protection appears at adjacent G·C-containing sites, indicating a compromised recognition code. Solid-phase synthesized mismatch libraries confirm that the central pyrrole pair rejects G·C steps because of a steric clash between the guanine 2-amino group and the pyrrole H3 proton; the (3Z) geometry enforces a trajectory that places the amidine terminus away from this clash zone.

    Comparative binding profile of (3Z) and (3E) isomers by DNase I footprinting
    IsomerProtected A/T tract (bp)Kapp (nM⁻¹)Discrimination ratio (A/T vs G/C)
    (3Z)6.5 ± 0.32.1 × 10⁻²>100
    (3E)5.8 ± 0.59.4 × 10⁻³~45

    The table above summarizes footprinting results obtained at 4 °C with 5 mM MgCl₂ and 2 mM CaCl₂. The Kapp values are apparent association constants derived from half-maximal protection and are referenced to the same DNA fragment under identical buffer conditions.

    Storage and Light-Sensitivity Protocols

    Dry powder retains > 90% bioactivity after 24 months at −80 °C when hermetically sealed and desiccated. At ambient room temperature (22–24 °C) the compound undergoes gradual photo-oxidation of the pyrrole rings, forming dark-brown oligomeric species with negligible DNA-binding capacity. Exposure to laboratory fluorescent lighting for 8 h reduces the absorbance at 310 nm by 12–15%. All handling is therefore performed under subdued incandescent light or amber-filtered illumination. Reconstitution in oxygen-free buffer, purged with helium for 20 min, is recommended for biophysical assays requiring long-term stability beyond 6 h at 4 °C.

    In large-scale preparative HPLC, the product elutes as a single sharp peak at 18.2 ± 0.2 min on a C18 column (250 × 4.6 mm, 5 μm particle size) with a linear gradient of 5–60% acetonitrile in 0.1% trifluoroacetic acid over 30 min. This retention time is consistent across ≥ 20 consecutive purification runs when column temperature is held at 40 °C. Minor shoulders (< 2% area) sometimes appear at 17.5 min, corresponding to des-amidine hydrolysis product; these fractions are discarded to maintain the certified purity.

    When the Amidine Terminal Group Is Replaced by Guanidine in Comparative Analogs

    A series of isosteric derivatives in which the C-terminal amino-iminopropylamidine is substituted by a guanidinopropyl group were evaluated under identical DNase I footprinting conditions. The guanidine analog exhibits 3.5-fold weaker binding at the consensus 5′-AATTAA-3′ site and fails to protect the minor groove against DNase I cleavage at concentrations below 500 nM. Molecular dynamics simulations at the AMBER ff19SB force field level indicate that the guanidine group distorts the groove width by 0.8–1.1 Å, disrupting the complementary hydrogen-bond network between the pyrrole amides and the floor of the groove. In contrast, the (3Z)-amino-iminopropylamidine adopts a planar, resonance-stabilized geometry that mimics the natural curvature of the polyamide backbone, avoiding the steric penalty.

    Atypical Electrophoretic Mobility Shift Behavior

    When the ligand is pre-incubated with 32P-labeled duplex 5′-GCTTAATTAAGC-3′ at 4 °C for 30 min and resolved on a native 10% polyacrylamide gel (TBE buffer, pH 8.0), a single retarded band appears with a mobility shift of 0.38 ± 0.03 relative to free DNA. The bound complex resists dissociation during electrophoresis for ≥ 2 h, a kinetic stability uncommon among monomeric pyrrole-imidazole polyamides. This property enables the compound to serve as a covalent-like blocking reagent in exonuclease III protection assays. Users must, however, note that complex formation is exquisitely sensitive to Na⁺ concentration; above 150 mM NaCl the retarded band intensity drops to < 20% of the maximum observed at 50 mM.

    Operational buffer parameters for DNA-binding assays (EMSA and protection)
    ParameterOptimal rangeCritical threshold
    pH (Tris or cacodylate)7.2–7.6< 6.8 causes amidine protonation shift
    NaCl or KCl40–80 mM> 120 mM weakens binding by > 50%
    MgCl₂0–5 mM> 10 mM induces non-specific groove contraction
    DMSO (from stock)< 2% v/v> 5% promotes ligand aggregation detectable by light scattering

    The compound finds use as a molecular probe in fluorescence anisotropy displacement experiments when a 5′-FITC-labeled cognate duplex is employed. The displacement midpoint provides a convenient rank-order for unlabeled competitors. Published data for this specific configuration in live-cell nuclear targeting studies is limited, though microinjection into D. melanogaster salivary glands at 50 nM results in detectable enrichment at polytene chromosomal bands rich in A/T satellite repeats after 15 min incubation.

    Unexpected precipitation occurs when the stock solution is mixed with buffers containing phosphate at concentrations ≥ 50 mM, as the diamino-methylidene moiety forms insoluble phosphate adducts. Similarly, combination with amine-based reducing agents such as TCEP should be avoided due to imine bond reduction risk; DTT at 1 mM is tolerated for < 2 h without measurable loss of binding activity.

    Batch certificates report endotoxin levels < 0.05 EU mg⁻¹ when tested by the LAL chromogenic method per USP <85>, supporting application in cell-based assays where TLR4 activation must be avoided. For researchers comparing this reagent with widely distributed hairpin polyamides, the absence of an internal γ-turn residue simplifies the synthetic route and results in a molecular weight advantage of approximately 200 Da, which can be critical for passive diffusion across nuclear pore complexes. Yet the linear, non-hairpin architecture imposes a higher entropic penalty upon binding; the melting temperature of a 12-mer A/T duplex is increased by only 6.2 °C at 2:1 ligand:duplex ratio, whereas the analogous hairpin elevates Tm by 11.5 °C. This thermal denaturation differential reflects the fundamentally monomeric binding mode, confirmed by Job plot analysis indicating a 1:1 stoichiometry.

    Mechanistic investigations using surface plasmon resonance on a streptavidin-coated sensor chip with a 5′-biotin-T10-A10-3′ surface show an association rate constant ka2.0 × 10⁵ M⁻¹ s⁻¹ and a dissociation rate constant kd4.0 × 10⁻⁴ s⁻¹ at 25 °C, giving an equilibrium constant KD of approximately 2.0 nM. The sensorgram fits a simple Langmuir model with χ² < 2.0, consistent with the absence of cooperative interactions.

    Differentiating the Linear Architecture from Hairpin Polyamides

    Three operational distinctions deserve emphasis. First, the linearized structure permits easier conjugation to fluorophores or biotin through the free N-terminus without compromising the binding domain, a strategy confirmed by solid-phase coupling of 5(6)-TAMRA to the N-terminal amine after selective deprotection. Second, in chromatin immunoprecipitation-grade assays, the compound dissociates within 5 min under 0.1% SDS at 65 °C, enabling crosslink reversal and DNA recovery with minimal chemical footprint. Third, because the compound lacks a chiral turn unit, synthetic yields for multi-gram scale GMP production are ≤ 25% higher than for equivalent hairpin oligomers, yet the overall cost-of-goods remains elevated by the chromatographic polishing step required to separate the (3E) byproduct, which typically constitutes 8–12% of the crude reaction mass.

    In cell-free transcription systems containing HeLa nuclear extract and a TATA-box-driven template, the ligand represses RNA polymerase II initiation with an IC50 of 30 nM, compared to 120 nM for netropsin under identical conditions. This tenfold potency gain reflects the extended recognition surface that encompasses 2 additional base pairs in the TATA element. However, transcriptional repression is not sustained beyond 2 h in the presence of ATP-regenerating system components, suggesting active displacement by chromatin remodeling factors.

    Characterization by ¹H NMR (DMSO-d₆, 600 MHz) shows sharp amide proton resonances between 9.5–10.2 ppm that exchange slowly on the chemical shift timescale, indicative of strong intramolecular hydrogen bonding. High-resolution mass spectrometry confirms the monoisotopic peak at m/z 515.2368 ([M+H]⁺, Δ < 2 ppm). Elemental analysis for C₂₃H₃₀N₁₀O₃·TFA·H₂O returns C, H, N within ±0.3% of theoretical values, consistent with a trifluoroacetate salt form obtained by lyophilization from 0.1% TFA.

    Protective packaging complies with IATA PI 650 for non-infectious diagnostic specimens when shipped on dry ice. Laboratories receiving the product should immediately transfer the unopened vial to a −20 °C freezer equipped with continuous temperature monitoring. Once reconstituted, the solution should not be refrozen; aggregate formation monitored by dynamic light scattering yields a Z-average diameter increase from 1.2 nm (monomer) to 45 nm after 2 freeze–thaw cycles.